Skip to main content
OpenTrials

Clinical trial condition

Thromboembolism

Explore clinical trials studying Thromboembolism. Study availability and eligibility vary by location and protocol.

543 public trials 85 recruiting studies
Refine in advanced search Browse all conditions

Thromboembolism trial results

Completed

Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty

NCT01713361

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations
  • Isis Investigational Site Plovdiv, Bulgaria
  • Isis Investigational Site Rousse, Bulgaria
  • Isis Investigational Site Sofia, Bulgaria
  • Isis Investigational Site Ajax, Ontario, Canada
View all 21 locations
View Trial Details
Completed

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

NCT00657150

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations
  • 1160.64.01005 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 1160.64.01010 Boehringer Ingelheim Investigational Site Aurora, Colorado, United States
  • 1160.64.01009 Boehringer Ingelheim Investigational Site Englewood, Colorado, United States
  • 1160.64.01012 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States
View all 108 locations
View Trial Details
Completed

Crux Biomedical Vena Cava Filter Study - United States

NCT01120509

Conditions
Cardiovascular Diseases, Embolism, Embolism and Thrombosis, +6 more
Locations
  • St. Joseph's Hospital Orange, California, United States
  • University of California at Irvine Medical Center Orange, California, United States
  • Univeristy of California at Davis Medical Center Sacramento, California, United States
  • Christiana Care Newark, Delaware, United States
View all 17 locations
View Trial Details
Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

NCT00558259

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations
  • 1160.63.01025 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1160.63.01023 Boehringer Ingelheim Investigational Site Huntsville, Alabama, United States
  • 1160.63.01002 Boehringer Ingelheim Investigational Site Laguna Hills, California, United States
  • 1160.63.01014 Boehringer Ingelheim Investigational Site Colorado Springs, Colorado, United States
View all 147 locations
View Trial Details
Completed

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Thromboembolism, +2 more
Locations
  • 1160.19.43004 Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria
  • 1160.19.43002 Orthopädisches Spital Speising Vienna, Austria
  • 1160.19.43001 A.ö. Krankenhaus d. Statutarstadt Wiener Neustadt Wiener Neustadt, Austria
  • 1160.19.32002 V.U.B. Jette Brussels, Belgium
View all 59 locations
View Trial Details

Related conditions